Recently, Li Jingguo’s team from People’s Hospital of Zhengzhou University and Professor Shuai Xintao’s team from Zhongshan University have made a new progress on nano-drugs against rheumatoid arthritis (RA).
The related research results are presented in the academic paper “Inflammation-Targeted Celastrol Nanodrug Attenuates Collagen-Induced Arthritis through NF-κB and Notch1 Pathways”, which was published in the internationally renowned journalNano Letters.